Centene (NYSE:CNC) has become the latest health insurer to take the U.S. Centers for Medicare & Medicaid Services (CMS) to court over the agency’s Medicare Advantage Star Ratings for next year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback